Skip to content
Tenfell
Awarded contract
Published 07 Dec 2020

Supportive Medicines including ITU, EOL & Antibiotics

Department of Health and Social Care · London

Key facts

Awarded
13 Sep 2020
Contract starts
16 Sep 2020
Contract ends
31 Aug 2021
Procedure
Accelerated Open procedure (above threshold)
Buyer type
Central government

Awarded to 32 suppliers

SupplierValue
FRESENIUS KABI LIMITED—
Baxter Healthcare Ltd—
Bowmed Ibisqus Limited—
Consilient Health Ltd—
Crescent Pharma Limited—
Martindale Pharma—
Pfizer Ltd—
Ranbaxy (UK) Ltd—
Teva UK Ltd—
Aventis Pharma Ltd T/A Sanofi—
B. Braun Medical Limited—
Ennogen Healthcare Ltd—
Thornton & Ross Ltd—
Wockhardt UK Limited—
Accord-UK Ltd—
Kent Pharma Ltd—
Mylan—
Novo Nordisk—
Zentiva Pharma UK Ltd—
Amarox Limited—
Drugsrus Ltd—
Milpharm Ltd/aurobinbdo—
Strandhaven Ltd t/a Somex Pharma—
Syri Limited (T/A Thame Laboratories)—
Tillomed Laboratories ltd—
FLYNN PHARMA LTD—
Intrapharm Laboratories Ltd—
hameln pharma ltd—
Mercury Pharmaceuticals Limited—
Torbay Pharmaceuticals—
Techdow Pharma England Ltd—
Synchrony Pharma Ltd—

Description

A procurement exercise for supportive medicines that includes End of Life, Intensive Treatment Unit and Antibiotics medicines.

Categories (CPV)

Similar open tenders

About Department of Health and Social Care

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on Contracts Finder archive (Open Contracting) (Open Government Licence v3.0). Always read the original notice before responding.